| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0076 | 1 |